Modifying a patient's dosage of the antiplatelet drug clopidogrel for 6 months depending on the patient's level of platelet reactivity did not result in combined lower rates of nonfatal heart attack, stent thrombosis (clot) ...
Mar 15, 2011
not rated yet
0
Research led by T. Cooper Woods, PhD, Assistant Professor of Pharmacology and Experimental Therapeutics at LSU Health Sciences Center New Orleans, and Director of the Molecular Cardiology Research Laboratory at Ochsner Clinic ...
Apr 14, 2010
5 / 5 (1)
0
Several large observational data sets have convincingly shown that there is no overall safety issue with drug eluting stents (DES) vs. bare metal stents (BMS). In fact, most registry studies suggest a lower risk of death ...
Aug 31, 2009
not rated yet
0
E-mail, search engines, smart phones and other new technologies that can disseminate new medical information quickly led to an almost immediate change in clinical practice for drug-eluting stents, according to a study reported ...
Jul 28, 2009
not rated yet
0
A study published today online in The Lancet (March 13, 2009) presented two year data for the bioabsorbable everolimus coronary stent. Commenting on the results, interventional cardiology specialist, Professor Franz Eberli ...
Mar 13, 2009
not rated yet
0
